Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,383 | -5,642 | -2,885 | -501 | -141 |
| Depreciation Amortization | 15 | 9 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 5,925 | 3,366 | 782 | N/A | N/A |
| Other Working Capital | 6,768 | 4,220 | 1,683 | 178 | -12 |
| Other Operating Activity | -5,618 | -3,161 | -680 | -68 | -4 |
| Operating Cash Flow | $-1,293 | $-1,208 | $-1,100 | $-391 | $-157 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -137 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-137 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 4,088 | 4,088 | 4,088 | 479 | 479 |
| End Cash Position | 2,659 | 2,880 | 2,988 | 88 | 322 |
| Net Cash Flow | $-1,429 | $-1,208 | $-1,100 | $-391 | $-157 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,293 | -1,208 | -1,100 | -391 | -157 |
| Free Cash Flow | -1,293 | -1,208 | -1,100 | -391 | -157 |